1. Home
  2. ACN vs ABT Comparison

ACN vs ABT Comparison

Compare ACN & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Accenture plc (Ireland)

ACN

Accenture plc (Ireland)

HOLD

Current Price

$273.18

Market Cap

181.4B

ML Signal

HOLD

Logo Abbott Laboratories

ABT

Abbott Laboratories

HOLD

Current Price

$127.20

Market Cap

222.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACN
ABT
Founded
1989
1888
Country
Ireland
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
181.4B
222.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACN
ABT
Price
$273.18
$127.20
Analyst Decision
Buy
Strong Buy
Analyst Count
22
18
Target Price
$301.05
$146.61
AVG Volume (30 Days)
4.0M
6.7M
Earning Date
12-18-2025
01-21-2026
Dividend Yield
2.40%
1.86%
EPS Growth
6.28
141.97
EPS
12.15
7.96
Revenue
$69,672,977,000.00
$43,843,000,000.00
Revenue This Year
$6.73
$7.56
Revenue Next Year
$5.40
$7.96
P/E Ratio
$22.39
$15.94
Revenue Growth
7.36
6.37
52 Week Low
$229.40
$110.86
52 Week High
$398.35
$141.23

Technical Indicators

Market Signals
Indicator
ACN
ABT
Relative Strength Index (RSI) 64.22 52.58
Support Level $265.01 $120.70
Resistance Level $277.65 $129.64
Average True Range (ATR) 6.79 2.31
MACD 1.17 0.26
Stochastic Oscillator 74.69 70.49

Price Performance

Historical Comparison
ACN
ABT

About ACN Accenture plc (Ireland)

Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Share on Social Networks: